Thousands of pharmacies could close if they do not receive extra funding to cope with COVID-19 pressures as around half were already in deficit at the start of the pandemic, the National Pharmacy Association has told the government.
Pharmacy leaders in the black, Asian and minority ethnic communities have expressed concern that assessments of black, Asian and minority ethnic staff’s susceptibility to COVID-19 are not widespread enough in community pharmacy.
Community pharmacies will receive a further £50m of advance funding from the government to help with cash flow pressures during the COVID-19 pandemic, the Pharmaceutical Services Negotiating Committee has announced.
Pharmacy inspectors may ask to see risk assessments made by pharmacies when they employ pharmacists who are provisionally-registered during the COVID-19 pandemic.
Pre-exposure prophylaxis drugs will be routinely commissioned by local authorities in a phased approach during the 2020/2021 financial year, the government has said.
Boots saw its profits fall by almost 50% in 2019, owing to “lower revenue and gross margin”, according to financial accounts filed to Companies House and published on 18 May 2020.
The use of corticosteroids in coronavirus infections is associated with increased risk of death and side effects, such as bacterial infections and hypokalaemia, researchers have said.
Among people with hypertension, the severity of COVID-19 is not associated with the use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, data from Wuhan, China, suggest.
Daily multidisciplinary team (MDT) meetings significantly reduced the length of hospital stay for patients with COPD, a study published in the Journal of the American Osteopathic Association has found.
Adults with non-valvular atrial fibrillation prescribed apixaban have a lower rate of ischaemic stroke and systemic blood clots compared with those prescribed rivaroxaban, according to a retrospective cohort study in Annals of Internal Medicine.
Neurological symptoms are common in patients with COVID-19, particularly if they have a severe infection, research published in JAMA Neurology suggests.
The development of myocardial injury in COVID-19 patients is associated with an increased risk of death, researchers have found.